User:MIKHEIL/exercise
Rati Golijashvili | |
|---|---|
| Born | ? |
| Occupation | Healthcare entrepreneur |
Rati Golijashvili (Born date?) is a Georgian healthcare entrepreneur and an advocate in the global fight against antimicrobial resistance (AMR).
Biography
Born and raised in Tbilisi, Georgia, in a family of microbiologists and pharmacists, Golijashvili's passion for biotechnology and healthcare was deeply influenced by his upbringing. He holds a Master of Public Health.
Golijashvili is the CEO of BioChimPharm[citation needed], a biopharmaceutical company based in Georgia, known for its groundbreaking work in phage therapy.[citation needed] Under his leadership, BioChimPharm has developed a phage technology platform that effectively substitutes traditional antibiotics, offering a sustainable solution to antibiotic-resistant infections.[citation needed]
Rati’s efforts in bringing life-saving medications to patients suffering from antibiotic-resistant infections globally and achievements in this area have earned the company numerous international awards, including recognitions from Forbes[citation needed], Horizon Europe[citation needed], the European Commission, The World Bank[citation needed], the European Bank for Reconstruction and Development (EBRD)[citation needed], and the Food and Agriculture Organization (FAO).[citation needed]
In 2022, Golijashvili led the development of the first in its category, a robotized, high-tech, sterile manufacturing facility aimed at increasing the production capacity of life-saving novel antibiotics.[citation needed] This facility has enabled BioChimPharm to produce tens of millions of vials (Phage preparations) annually[citation needed], helping to address the growing crisis of antibiotic resistance and improve preparedness for future pandemics.
Apart from his role at BioChimPharm, Golijashvili is the Chairman of the Georgian Biopharmaceutical Cluster[citation needed] and a Board Member of the Georgian Pharmaceutical Association[citation needed]. He also serves on the Advisory Board of the Education and Science Committee in the Parliament of Georgia[citation needed], where he contributes to policy development and innovation in education.
Golijashvili has participated in numerous public speaking engagements, including a TEDx talk in 2019[citation needed], where he highlighted the critical need for large-scale adoption of phage therapy. He has also addressed international forums, such as the United Nations' annual meeting in 2022[citation needed], emphasizing the urgency of combating AMR through innovative solutions.
Rati Golijashvili has been recognized twice on the Forbes 30 Under 30 list[citation needed], first in Science (2018) and later in Manufacturing & Industry (2019)[citation needed]. He is also a jury member for the Forbes 30 Under 30 list[citation needed], where he continues to support young scientists in their respective fields.
Golijashvili is the author of two international patents related to phage technology and its application in treating antibiotic-resistant infections[citation needed].